PsyPost
  • Mental Health
  • Social Psychology
  • Cognitive Science
  • Neuroscience
  • About
No Result
View All Result
Join
My Account
PsyPost
No Result
View All Result
Home Exclusive Mental Health Parkinson's disease

Omega-3 supplements protect the brain’s breathing center in Parkinson’s disease model

by Bianca Setionago
June 13, 2026
Reading Time: 3 mins read
[Adobe Stock]

[Adobe Stock]

Omega-3 fish oil supplements preserved the brain regions that control breathing and restored normal breathing rates in mice with a Parkinson’s disease-like condition, according to new research published in the journal Neuroscience.

Parkinson’s disease is a brain disorder known for causing tremors, stiffness, and slow movement—symptoms that stem from the gradual death of dopamine-producing brain cells. In the advanced stages of the disease, many patients develop impaired breathing, and pneumonia resulting from this is the leading cause of death. These breathing problems are thought to arise because the disease eventually damages specific regions of the brainstem controlling automatic functions like breathing and heart rate.

Despite the serious consequences of these breathing complications, the standard treatment for Parkinson’s (levodopa) has little to no effect on this aspect of the disease. Levodopa replenishes dopamine to help with movement, but it does not target the underlying processes of inflammation and cellular damage that drive non-movement-related deterioration.

This has left researchers searching for additional treatments that could address these gaps. Scientists were drawn to omega-3 fatty acids (the active ingredients in fish oil supplements) because of their well-known anti-inflammatory and antioxidant properties.

Led by Taina O. Macedo from the University of São Paulo in Brazil, the team utilized 52 mice to model the disease. The mice were divided into four groups: a healthy control group, a healthy group given omega-3, a Parkinson’s model group, and a Parkinson’s model group treated with omega-3.

To create the Parkinson’s model, researchers injected a chemical called 6-hydroxydopamine directly into the brain. Omega-3 supplementation began five days after the injections and continued for ten days—a deliberate timing choice, since by day five the dopamine cell damage was already well established, but the brainstem breathing regions had not yet fully deteriorated. Breathing was assessed using a specialized sealed chamber, and brain tissue was later examined under a microscope to count surviving neurons and assess immune cell activity.

As expected, the omega-3 supplements did not reverse or prevent the loss of dopamine-producing brain cells. However, in mice that received omega-3, the number of surviving neurons in the brainstem breathing regions was preserved at levels comparable to healthy control mice. Without omega-3, these same regions showed significant cell loss in Parkinson’s model animals.

The cellular environment also differed markedly. In the Parkinson’s model mice that did not receive omega-3, the brain’s immune cells showed signs of a reactive, inflammatory state in the brain’s breathing regions. There were also elevated levels of harmful reactive oxygen species, which are a marker of oxidative stress and cellular damage. Omega-3 treatment reduced this oxidative stress and attenuated the abnormal immune cell changes in these regions.

Crucially, these cellular protections translated into a measurable functional benefit. Parkinson’s model mice breathed significantly more slowly than healthy mice at rest—around 161 breaths per minute compared to 183 in controls. Omega-3-treated Parkinson’s mice, however, breathed at a rate of roughly 183 breaths per minute—statistically indistinguishable from the healthy animals.

The researchers noted in the paper that these protective effects “are likely attributable to the antioxidant and anti-inflammatory properties of omega-3 fatty acids,” and that the findings “reinforce the therapeutic potential of omega-3 in neurodegenerative conditions.”

The study carries important limitations. Results in animals do not always translate to humans—particularly for a complex disease. Human clinical trials would be needed before any conclusions can be drawn about whether omega-3 supplements could benefit people living with Parkinson’s disease.

The study, “Omega-3 supplementation prevents functional and neural respiratory damage present in an animal model of Parkinson’s disease,” was authored by Taina O. Macedo, Lais M. Cabral, Nicole C. Miranda, Fulvio A. Scorza, Thiago S. Moreira, and Ana C. Takakura.

TweetSendScanShareSendPin1ShareShareShareShareShare

Follow PsyPost

The latest research, however you prefer to read it.

Daily newsletter

One email a day. The newest research, nothing else.

Google News

Get PsyPost stories in your Google News feed.

Add PsyPost to Google News
RSS feed

Use your favorite reader.

Copy RSS URL
Social media
Support independent science journalism

Ad-free reading, full archives, and weekly deep dives for members.

Become a member

Trending

  • Women want to talk about sex with their close friends more often, study finds
  • Scientists uncover how a tiny reflection of light helps us navigate the social world
  • Over 10 percent of factual claims in Google’s AI search summaries aren’t backed by their cited sources, study finds
  • Inflammation briefly dampens pleasure and the desire to socialize, placebo-controlled study finds
  • Narcissistic parents tend to lean on their children for emotional support, and that is linked to depression later on

Science of Money

  • For male startup founders, average looks may pay off best in the pitch room, according to new Shark Tank study
  • Why struggling with bills feels even worse when you think the economy is booming
  • Feeling stuck in an unwanted work location takes a measurable toll on mental health
  • Why having a self-sacrificing boss can feel like a trap, according to psychology
  • News about shortages only triggers stockpiling when shoppers start searching online, study finds

Recent

  • Loving-kindness meditation fails to beat muscle relaxation for pain or social well-being in online trial
  • Losing childhood weight by adulthood might erase later depression risks
  • Women don’t find deeper-than-average voices more attractive when they can see the man
  • Voters value long-term economic growth more than previously thought, study finds
  • Scientists map a blood protein fingerprint of menopause tied to brain health
  • Social anxiety might not warp how we perceive eye contact
  • In female mice modeling schizophrenia, a single dose of psilocybin restored sensory filtering for days
  • Could psychedelics aid therapy for personality disorders? An unusual case offers a first look
  • Schizophrenia is linked to broad difficulty reading emotions from body language and faces
  • Socially isolated and lonely people tend to be biologically older than their years

PsyPost is a psychology and neuroscience news website dedicated to reporting the latest research on human behavior, cognition, and society. (READ MORE...)

  • Mental Health
  • Neuroimaging
  • Personality Psychology
  • Social Psychology
  • Artificial Intelligence
  • Cognitive Science
  • Psychopharmacology
  • Contact us
  • Disclaimer
  • Privacy policy
  • Terms and conditions
  • FAQ

(c) PsyPost Media Inc

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In

Add New Playlist

Subscribe
  • My Account
  • Cognitive Science Research
  • Mental Health Research
  • Social Psychology Research
  • Drug Research
  • Relationship Research
  • About PsyPost
  • Contact
  • Privacy Policy

(c) PsyPost Media Inc